Vertex Pharmaceuticals (VRTX) Competitor Comparison
We are evaluating the key criteria listed to compare Vertex Pharmaceuticals (VRTX) against its competitors in the Biotechnology industry.
Market Capitalization
1 / 368Gross Profits
4 / 278Total Revenue
2 / 300EBITDA
2 / 337Free Cashflow
1 / 352Quick Ratio
237 / 357Earnings per Share
202 / 359Dividend yield
0 / 6Total Cash
1 / 358Performance 3 years
33 / 368Performance 5 years
71 / 368Performance 10 years
28 / 368Linearity 3 years
269 / 368Linearity 5 years
279 / 368Linearity 10 years
363 / 368Total Rank
58 / 368Dividend Rank
41 / 368Valuation Rank
36 / 368Piotroski Rank
5 / 368Muliplier Rank
231 / 368Dividend Rank - VRTX ranking 41 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.